Moss Genomics Secures $250,000 Through Private Placement and Acquires 160 ETH

Moss Genomics Announces Private Placement Closing, 160 Ethereum Acquisition And Adds Hunter Jordan To Board Of Directors

  • Moss Genomics completes private placement raising $250,000 through issuance of 2.5 million shares at $0.10 each.
  • Company acquires 160 Ethereum cryptocurrency through issuance of 7.84 million common shares.
  • Hunter Jordan, a real estate investment executive with CPA background, joins the Board of Directors.
  • Company grants 200,000 stock options to directors, officers, and consultants at $0.20 exercise price.
  • Strategic move combines biotechnology with blockchain treasury management.

Moss Genomics Inc. (CSE: MOSS) (FSE: F73) has completed a dual-track expansion, securing traditional equity financing while simultaneously advancing into the cryptocurrency space through a significant Ethereum acquisition.

- Advertisement -

The biotechnology company’s private placement generated $250,000 through the issuance of 2.5 million common shares priced at $0.10 each. In a parallel move, Moss acquired 160 ETH by issuing 7.84 million common shares, marking a significant entry into cryptocurrency treasury management.

Hunter Jordan, newly appointed to the company’s Board of Directors, brings strategic oversight from his position as VP at a private real estate firm. His appointment strengthens Moss’s governance structure as it navigates the intersection of biotechnology and blockchain technology.

The company’s innovative approach combines Artificial Intelligence and genomic research with blockchain integration, representing a novel convergence in the life sciences sector. To incentivize leadership, Moss granted 200,000 stock options to key personnel, exercisable at $0.20 per share over five years.

These developments are subject to Canadian Securities Exchange final acceptance, with securities under a standard four-month-plus-one-day holding period. The company plans to utilize proceeds from both transactions for working capital purposes, advancing its unique position in the biotechnology-blockchain nexus.

For U.S. investors, these securities remain unregistered under the U.S. Securities Act, with trading restricted to non-U.S. persons unless qualifying for exemption status.

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

- Advertisement -

Previous Articles:

Stay in the Loop

Get exclusive crypto insights, breaking news, and market analysis delivered straight to your inbox. No fluff, just facts.

    1 Email per day. Unsubscribe at any time.

    - Advertisement -

    Latest News

    Tornado Cash Co-Founder Roman Storm Guilty on Money Transmitting Charge

    Roman Storm, co-founder of crypto mixing tool Tornado Cash, was found guilty of operating...

    Predictors Bet on Bitcoin Surge, Vitalik’s Linea Mention, ETH Push

    Prediction markets show most participants expect Bitcoin to reach $125,000 before dropping to $105,000. A...

    SocGholish Malware Leveraging TDS for Sophisticated Web Attacks

    Attackers use Traffic Distribution Systems to spread the SocGholish Malware through compromised websites. SocGholish operates...

    OpenAI Launches Smarter, Faster GPT-5 AI Model for All Users

    OpenAI has launched the new ChatGPT-5 model, available to all users, including free accounts. ChatGPT-5...

    NYDFS Fines Paxos $26.5M Over Binance Ties, Orders Compliance Fix

    Paxos Trust reached a settlement with the New York Department of Financial Services (NYDFS),...

    Must Read

    What Are Anonymous Debit Cards And How Do They Work?

    You've heard about anonymous debit cards, but what are they really? Anonymous Debit Cards are cards that let you make purchases without revealing your...